These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9854758

  • 1. Opioid therapy for chronic noncancer back pain. A randomized prospective study.
    Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP.
    Spine (Phila Pa 1976); 1998 Dec 01; 23(23):2591-600. PubMed ID: 9854758
    [Abstract] [Full Text] [Related]

  • 2. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.
    J Opioid Manag; 2006 Dec 01; 2(6):325-8, 331-3. PubMed ID: 17326594
    [Abstract] [Full Text] [Related]

  • 3. [Long-term opioid therapy in chronic noncancer pain. A systematic review and meta-analysis of efficacy, tolerability and safety in open-label extension trials with study duration of at least 26 weeks].
    Häuser W, Bernardy K, Maier C.
    Schmerz; 2015 Feb 01; 29(1):96-108. PubMed ID: 25503691
    [Abstract] [Full Text] [Related]

  • 4. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
    Rauck RL, Bookbinder SA, Bunker TR, Alftine CD, Ghalie R, Negro-Vilar A, de Jong E, Gershon S.
    J Opioid Manag; 2006 Feb 01; 2(3):155-66. PubMed ID: 17319449
    [Abstract] [Full Text] [Related]

  • 5. Naproxen With Cyclobenzaprine, Oxycodone/Acetaminophen, or Placebo for Treating Acute Low Back Pain: A Randomized Clinical Trial.
    Friedman BW, Dym AA, Davitt M, Holden L, Solorzano C, Esses D, Bijur PE, Gallagher EJ.
    JAMA; 2015 Oct 20; 314(15):1572-80. PubMed ID: 26501533
    [Abstract] [Full Text] [Related]

  • 6. Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations.
    Ueberall MA, Mueller-Schwefe GH.
    Curr Med Res Opin; 2015 Oct 20; 31(7):1413-29. PubMed ID: 25942606
    [Abstract] [Full Text] [Related]

  • 7. A phase 3, randomized, double-blind comparison of analgesic efficacy and tolerability of Q8003 vs oxycodone or morphine for moderate-to-severe postoperative pain following bunionectomy surgery.
    Richards P, Riff D, Kelen R, Stern W.
    Pain Med; 2013 Aug 20; 14(8):1230-8. PubMed ID: 23802706
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial.
    Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, Kroenke K, Bair MJ, Noorbaloochi S.
    JAMA; 2018 Mar 06; 319(9):872-882. PubMed ID: 29509867
    [Abstract] [Full Text] [Related]

  • 11. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA, Vaughn B, Lagasse S, O'Connor M.
    Drugs Aging; 2017 Aug 06; 34(8):603-613. PubMed ID: 28600725
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of once-daily OROS hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: results of a 6-week, randomized, open-label, noninferiority analysis.
    Hale M, Tudor IC, Khanna S, Thipphawong J.
    Clin Ther; 2007 May 06; 29(5):874-888. PubMed ID: 17697906
    [Abstract] [Full Text] [Related]

  • 13. Comparison of epidural morphine and oxycodone for pain after abdominal surgery.
    Backlund M, Lindgren L, Kajimoto Y, Rosenberg PH.
    J Clin Anesth; 1997 Feb 06; 9(1):30-5. PubMed ID: 9051543
    [Abstract] [Full Text] [Related]

  • 14. Comparison of oral oxycodone and naproxen in soft tissue injury pain control: a double-blind randomized clinical trial.
    Fathi M, Zare MA, Bahmani HR, Zehtabchi S.
    Am J Emerg Med; 2015 Sep 06; 33(9):1205-8. PubMed ID: 26166378
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B, Ross E, Sasaki J, Weil A.
    Curr Med Res Opin; 2006 Aug 06; 22(8):1503-14. PubMed ID: 16870075
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME, Dvergsten C, Gimbel J.
    J Pain; 2005 Jan 06; 6(1):21-8. PubMed ID: 15629415
    [Abstract] [Full Text] [Related]

  • 17. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E, Belzile M, Pituskin E, Fainsinger R, Darke A, Harsanyi Z, Babul N, Ford I.
    J Clin Oncol; 1998 Oct 06; 16(10):3222-9. PubMed ID: 9779695
    [Abstract] [Full Text] [Related]

  • 18. Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
    Weil AJ, Masters ET, Barsdorf AI, Bass A, Pixton G, Wilson JG, Wolfram G.
    Health Qual Life Outcomes; 2017 Oct 17; 15(1):202. PubMed ID: 29041942
    [Abstract] [Full Text] [Related]

  • 19. Tolerability and efficacy of two synergistic ratios of oral morphine and oxycodone combinations versus morphine in patients with chronic noncancer pain.
    de la Iglesia FA, Pace GW, Robinson GL, Huang NY, Stern W, Richards P.
    J Opioid Manag; 2012 Oct 17; 8(2):89-98. PubMed ID: 22616314
    [Abstract] [Full Text] [Related]

  • 20. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D, Leyendecker P, Meissner W, Hopp M, Szombati I, Hermanns K, Ruckes C, Weber S, Grothe B, Fleischer W, Reimer K.
    J Pain; 2008 Dec 17; 9(12):1144-54. PubMed ID: 18708300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.